Emma Ryan

ORCID: 0000-0002-5909-9178
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Preterm Birth and Chorioamnionitis
  • Neonatal Respiratory Health Research
  • Venous Thromboembolism Diagnosis and Management
  • Central Venous Catheters and Hemodialysis
  • Neonatal and Maternal Infections
  • Antimicrobial Peptides and Activities
  • Oral microbiology and periodontitis research
  • Maternal and Perinatal Health Interventions
  • Maternal and fetal healthcare
  • Palliative Care and End-of-Life Issues
  • Cancer Genomics and Diagnostics
  • Childhood Cancer Survivors' Quality of Life
  • Clinical Nutrition and Gastroenterology
  • Probiotics and Fermented Foods
  • Nutrition, Health and Food Behavior
  • Machine Learning in Bioinformatics
  • Diagnosis and Treatment of Venous Diseases
  • Intraperitoneal and Appendiceal Malignancies
  • Respiratory and Cough-Related Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Ovarian cancer diagnosis and treatment
  • Cancer survivorship and care
  • Food Security and Health in Diverse Populations
  • Child Nutrition and Water Access
  • Cardiac, Anesthesia and Surgical Outcomes

Indiana University
2021-2025

University School
2025

Indiana University School of Medicine
2021-2025

Carnegie Mellon University
2023

Indiana University – Purdue University Indianapolis
2022-2023

Duke University
2020-2021

Duke Medical Center
2021

NYU Langone Health
2019

Northampton General Hospital NHS Trust
2017

Background: Access to high quality nutrition is an important part of a healthy pregnancy, and multiple risk factors for poor maternal have been identified. Objective: The objective this study was examine the relationship between self-reported diet residing in food desert during early pregnancy. Secondary outcomes included examining measures antenatal depression stress Study Design: This secondary analysis data collected Hoosier Moms Cohort study. Diet based on patient self-report via...

10.54053/001c.132350 article EN 2025-02-15

SPLUNC1 (short palate lung and nasal epithelial clone 1) is a multifunctional host defense protein found in human respiratory tract with antimicrobial properties. In this work, we compare the biological activities of four peptide (AMP) derivatives using paired clinical isolates Gram-negative (G(−)) bacteria Klebsiella pneumoniae, obtained from 11 patients with/without colistin resistance. Secondary structural studies were carried out to study interactions between AMPs lipid model membranes...

10.1021/acs.biomac.3c00218 article EN cc-by Biomacromolecules 2023-05-24

Two recent clinical trials have demonstrated that direct oral anticoagulants (DOACs) are effective as venous thromboembolism (VTE) prophylaxis in patients with moderate-to-high risk ambulatory cancer initiating chemotherapy. Patients advanced ovarian receiving neoadjuvant chemotherapy at particularly increased of VTE. We performed a cost-effectiveness analysis from health system perspective to determine if DOACs feasible prophylactic strategy this population.A simple decision tree was...

10.1200/op.20.00783 article EN JCO Oncology Practice 2021-04-29

With inhaled medication the primary treatment choice for UK's chronic obstructive pulmonary disease patients, Steven Hickey, Paul Beeson and colleagues evaluate efficacy of two different education strategies on inhaler technique in older patients

10.12968/pnur.2017.28.5.196 article EN Practice Nursing 2017-05-02

7074 Background: Venous thromboembolism (VTE) is a major cause of morbidity and mortality among cancer patients. The Apixaban for the Prevention Thromboembolism in High-Risk Ambulatory Cancer Patients (AVERT) randomized controlled trial concluded that apixaban safe effective option VTE prophylaxis high-risk ambulatory patients initiating new chemotherapy regimen. We performed cost-effectiveness analysis from health system perspective to determine if feasible prophylactic strategy this...

10.1200/jco.2020.38.15_suppl.7074 article EN Journal of Clinical Oncology 2020-05-20

10.1016/s0002-9378(23)00482-9 article EN American Journal of Obstetrics and Gynecology 2023-08-25

10.1016/s0002-9378(23)00565-3 article EN American Journal of Obstetrics and Gynecology 2023-09-25

10.1016/s0002-9378(23)00630-0 article EN American Journal of Obstetrics and Gynecology 2023-10-28

<h3>Objectives</h3> To describe the practice patterns and treatment of nonagenarians who initiated care with a gynecologic oncologist. <h3>Methods</h3> Retrospective chart review women aged 90 or older presented to oncologist between 10/09 12/18 at an urban academic medical center. Descriptive statistics utilized for variables interest. <h3>Results</h3> We identified 34 (median age 92, range 90–98): 10 (29%) had benign disease, 8 (24%) pre-malignancy suspected malignancy, 16 (47%)...

10.1136/ijgc-2019-igcs.385 article EN 2019-09-01

1515 Background: Next generation sequencing (NGS) testing of tumor tissue or blood is performed to identify ‘actionable’ mutations that might guide patient care. NGS incidentally germline associated with cancer syndromes. No distinction made between and somatic alterations on reports, thus confirmatory required. In this quality improvement (QI) initiative, we evaluated the frequency referrals genetic counseling (GC) for patients potentially heritable identified through testing. Methods: We...

10.1200/jco.2020.38.15_suppl.1515 article EN Journal of Clinical Oncology 2020-05-20
Coming Soon ...